Overview
Printcare supplies specialised printing, packaging and digital-media products across Sri Lanka and export markets, including East African corrugated packaging operations. The latest filing shows a sharp sales recovery and a return to operating profit, but finance costs and other charges still left the group in a loss. The company has also declared a rights issue to fund investment and working capital.
Price performance
CARE closed at LKR 37.50 on 16 September 2026. It fell 6.2% over three months, versus a 5.6% fall in the ASPI, so its recent decline was broadly market-like but slightly deeper.
The share sits at the bottom of its 52-week range. Its three-year record includes two material falls, with the deepest reaching 45% and not yet recovering. Median daily turnover was only LKR 106,362; a LKR 1 million order is more than everything that trades on a typical day (940% of it), making that order a very large part of a normal session.
Valuation
At 0.58 times P/B, the market price is paying 58 cents for each rupee of net assets, versus a manufacturing median of 1.70 times. It ranks at the 4th percentile among 29 sector peers on P/B, an extreme discount that reflects a weak earnings base rather than a conventional P/E valuation, which is unavailable because trailing earnings are negative.
The share is "cheaper than 90% of days since February 2012" on P/B. However, trailing ROE was negative 17.3%, so book value is not currently producing a return for shareholders. No dividend is on record in the last two years; the recorded payout was LKR 2.00 in FY2024 and LKR 5.50 in FY2023.
News and sentiment
Direct coverage was normal, with two material articles in the past 90 days, both neutral in tone. A 16 September report described a LKR 700 million rights issue, while the company had declared the 19:70 rights issue on 15 September at LKR 30 per share.
The March and April disclosures concerning Printcare Digital identified an investment in that entity, but the available summaries do not disclose terms that would allow its earnings effect to be sized.
Financials
June-quarter revenue rose 55.4% year-on-year to LKR 4.2 billion, and operating profit turned positive at LKR 277 million. Gross margin was 16.9% versus 20.1% a year earlier, operating margin was 6.6% versus negative 0.2%, and net margin was negative 0.8% versus negative 11.0%. The group therefore made money from operations again, but still lost less than one cent on each rupee of sales after costs outside operations.
The net loss narrowed by LKR 261.8 million to LKR 35.4 million, but a LKR 312.5 million below-the-line drag absorbed the operating profit. June gross margin was among the worst of its seven comparable June quarters, while operating and net margins were middling against the respective comparable June records.
The twelve months to June 2026, reconstructed from interim filings rather than an audited full year, still carried a net margin of negative 9.8%. The latest annual filing showed equity of LKR 5.3 billion, down from LKR 7.1 billion a year earlier; the balance-sheet share count was unchanged at 86.0 million.
Risks
The leading risk is leverage. At March 2026, total debt was LKR 11.5 billion, equal to 204.7% of owners' equity, meaning lenders have funded more than twice the capital attributable to shareholders. Operating profit did not cover the interest bill, with interest cover at negative 0.79 times.
The current ratio was 1.18 times, meaning the group had LKR 1.18 of short-term assets, including inventories and customer receivables, for every LKR 1.00 of bills due within a year. Annual operating cash flow was 1.27 times operating profit, but free cash flow was a negative LKR 1.5 billion after capital spending, leaving internally generated cash insufficient for investment needs.
The announced rights issue highlights the funding requirement. As at 16 September 2026, higher oil prices and a weaker rupee were also part of the manufacturing backdrop, creating potential energy, logistics and import-cost pressure for an export-oriented packaging producer.
Outlook
As at 16 September 2026, the next operating evidence is the September interim quarter, expected to be filed between 6 and 14 November. It will show whether the June operating recovery extended beyond a single quarter and whether the loss after finance costs continued to narrow.
The declared rights issue has no ex-date yet; its estimated ex-date window runs from 10 October 2026 to 3 January 2027. Its stated purpose is investment and working capital, but the available data cannot establish the eventual earnings return on those funds or the final effect on per-share figures.